|
C2ORF15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.633400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.185800E-01 |
| Normal-vs-Stage2 |
5.715200E-01 |
| Normal-vs-Stage3 |
1.315380E-01 |
| Normal-vs-Stage4 |
7.663000E-01 |
| Stage1-vs-Stage2 |
6.795200E-01 |
| Stage1-vs-Stage3 |
1.250220E-01 |
| Stage1-vs-Stage4 |
8.836200E-01 |
| Stage2-vs-Stage3 |
4.499600E-01 |
| Stage2-vs-Stage4 |
8.884800E-01 |
| Stage3-vs-Stage4 |
4.552600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.087400E-01 |
| Normal-vs-AfricanAmerican |
9.727200E-01 |
| Normal-vs-Asian |
2.689400E-01 |
| Caucasian-vs-AfricanAmerican |
5.379200E-01 |
| Caucasian-vs-Asian |
5.002000E-01 |
| AfricanAmerican-vs-Asian |
4.022800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.553200E-01 |
| Normal-vs-Female |
4.652000E-01 |
| Male-vs-Female |
4.749800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.444600E-01 |
| Normal-vs-Extreme_Weight |
1.816840E-01 |
| Normal-vs-Obese |
8.264000E-01 |
| Normal-vs-Extreme_Obese |
6.066600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.829200E-01 |
| Normal_Weight-vs-Obese |
2.988600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.336400E-01 |
| Extreme_Weight-vs-Obese |
2.039200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.279000E-01 |
| Obese-vs-Extreme_Obese |
5.528000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.268800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.359600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.287000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.195830E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.379000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.150000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.489700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.909600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.344000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.670200E-01 |
| Normal-VS-Type2 PRCC |
2.833300E-04 |
| Normal-VS-KIRP CIMP |
5.468600E-01 |
| Normal-VS-Unclassified PRCC |
9.004000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.44099998389669E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.232400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.495000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.942600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.382400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.398200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.108400E-02 |
| Normal-vs-N1 |
3.303600E-01 |
| Normal-vs-N2 |
3.678000E-01 |
| N0-vs-N1 |
2.191200E-01 |
| N0-vs-N2 |
7.855600E-01 |
| N1-vs-N2 |
7.537600E-01 |
|
|
